Skip to main content

Professor of Ophthalmology


Comprehensive Eye Care
Soft contact lens
Dry eye disease
Cataract diagnosis
Ocular systemic conditions
Ocular surface disorders
Laser Treatment: Glaucoma & Secondary Cataracts

Education & Training

Research Fellowship (Pre-Medical School)
Bascom Palmer Eye Institute (Miami, FL)
(FL Lions Eye Bank)

Medical School
University of Florida (Gainesville, FL)

Post-doctoral Research Fellowship
University of Florida (Gainesville, FL)
Glaucoma and Ocular Pharmacology

Duke University Medical Center

Bascom Palmer Eye Institute (Miami, FL)

Research Interests

Ocular surface optimization, Dry eye pharmacology, Toxicology of the eye, Ocular Pharmacology

Professor of Ophthalmology Dr. Friedland completed medical school at the University of Florida (UF), as well as a post-doctoral research fellowship at UF in Glaucoma and Ocular Pharmacology that earned her a National Research Service Award. Her pre-medical school research fellowship (glaucoma and cornea) and residency at the Bascom Palmer Eye Institute (Miami, FL) shaped a career path distinguished in treating a diversity of ophthalmic and ocular surgery patient cases in institutional and private practice and in advancing innovation-driven research.

Post-training, Dr. Friedland founded Park Ophthalmology (Raleigh, NC) in 1984 and led a fast-growing regional ophthalmology and ocular surgery practice as its Medical Director. The same year Park Ophthalmology opened its doors, Dr. Friedland brought high-volume private practice to academia through joining UNC Ophthalmology as adjunct teaching faculty. Her decades of faculty ties to the Department culminated in her March 2020 appointment to full faculty at UNC.  In early 2020, Dr. Friedland’s regional private practice was integrated into UNC Medical Center’s ophthalmology service lines. The merger of Park Ophthalmology and UNC Ophthalmology was cited as instrumental to opening UNC Ophthalmology’s newest regional outpatient clinic in Raleigh, NC, in November 2020.

Dr. Friedland’s primary research interests include ocular surface optimization, dry eye pharmacology, toxicology of the eye and ocular pharmacology. She is an investigator and a sub-investigator on several studies examining ocular surface toxicity of cancer chemotherapeutic treatments. She also serves as onsite Principal Investigator for UNC Ophthalmology’s participation in Phase 1-4 clinical trials, including in the multi-center Ocular Herpes Zoster longitudinal study.

To make an appointment with Dr. Friedland at UNC Kittner Eye Center or UNC Park Ophthalmology, call 984-974-2020.

Beth Friedland, MD